| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |